GDP in Frontline Chemotherapy for Patients With PTCL-NOS

Clinical trial NCT02404571 · UNKNOWN

Trial details

NCT number: NCT02404571
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2011-01-01
Primary completion: 2016-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.